Process for predicting the prognosis of squamous cell lung cancer
View Patent ↗Disclosed in this specification is a method for predicting the prognosis of squamous cell lung cancer by observing regulatory changes in select miRNA sequences. These sequences may include hsa-mir-146b, hsa-mir-191, hsa-mir-206, hsa-mir-299-3p, hsa-mir-155, hsa-mir-15a, hsa-mir-122a, hsa-mir-513, hsa-mir-184, hsa-mir-511, hsa-mir-100, hsa-mir-10a, hsa-mir-453, hsa-mir-379, hsa-mir-202, hsa-mir-21, hsa-mir-126, hsa-mir-494, hsa-mir-432, hsa-mir-370, and combinations of these sequences.
1. A process for predicting the prognosis of squamous cell lung cancer in humans comprising the steps of:
extracting total RNA from a sample of lung tissue;
observing up regulation change of SEQ ID NO. 15 within extracted RNA relative to the same microRNA in a wild type lung tissue sample; and
predicting a poorer prognosis of squamous cell lung carcinoma based on the observation than would be the case if no up regulation was observed.
2. A process for predicting the prognosis of squamous cell lung cancer in humans comprising the steps of:
observing up regulation change of SEQ ID NO. 15 within extracted RNA relative to the same microRNA in a wild type lung tissue sample; wherein the step of observing includes the step of performing a quantitative polymerase chain reaction; and
predicting a poorer prognosis of squamous cell lung carcinoma based on the observation than would be the case if no up regulation was observed.
3. A process for predicting the prognosis of squamous cell lung cancer in humans comprising the steps of:
observing the abundance of SEQ ID NO. 15 within a sample, wherein the step of observing includes the step of performing a quantitative polymerase chain reaction; and
predicting a prognosis of squamous cell lung carcinoma based on the observation.